The following paper was accepted for publication
-
Strategies for modifying drug residence time and ocular bioavailability to decrease treatment frequency for back of the eye diseases.
Shatz W, Aaronson J, Yohe S, Kelley RF, Kalia YN.
Expert Opin Drug Deliv. 2018 Nov 29. doi: 10.1080/17425247.2019.1553953